Skip to main content
HR 4714 114th Congress House

Removing Barriers to Clinical Research Act of 2016

Official title: To amend title XVIII of the Social Security Act to ensure Medicare coverage of certain costs associated with FDA-approved clinical trials.

Introduced: March 3, 2016 Introduced by: Young, Todd Republican · Indiana See on congress.gov
Health Health technology, devices, suppliesMedicare
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2016
Referred to the Subcommittee on Health.
Mar 4, 2016
Referred to the Subcommittee on Health.
Mar 3, 2016
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 3, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 9, 2016

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Removing Barriers to Clinical Research Act of 2016

This bill amends title XVIII (Medicare) of the Social Security Act to expand Medicare coverage of costs associated with clinical trials. Under current law, Medicare covers routine costs of care furnished to a beneficiary enrolled in a category A (experimental) clinical trial of a medical device intended for use in the diagnosis, monitoring, or treatment of an immediately life-threatening disease or condition. The bill requires Medicare to also cover, with respect to a beneficiary enrolled in a category B (non-experimental) clinical trial, routine costs of care as well as the cost of the device under investigation.

A trial of a medical device shall, for purposes of Medicare coverage, be deemed to meet the definition of a category A or category B clinical trial, as the case may be, if the trial is conducted under the Federal Food, Drug, and Cosmetic Act's investigational use exemption.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Democratic 1
D
Peters, Scott H.
California · Mar 3, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4714: Removing Barriers to Clinical Research Act of 2016. 114th Congress. Open America. https://openamerica.io/bill/114-HR-4714/
MLA
"H.R. 4714: Removing Barriers to Clinical Research Act of 2016." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-4714/.
Bluebook (legal)
H.R. 4714, 114th Cong. (2026), https://openamerica.io/bill/114-HR-4714/.
Markdown link
[H.R. 4714: Removing Barriers to Clinical Research Act of 2016](https://openamerica.io/bill/114-HR-4714/)
Report a problem